Both AKT and JNK inhibition blocked EDN‐induced glioma cell migration (Hsieh et al, 2014), and AKT inhibition prevented EDNRA‐mediated migration of hepatocellular carcinoma cells (Cong et al, 2016). Here, AKT1 is linked to hepatocellular carcinoma.